Tag: Howard Lam
GSK to acquire Chimagen asset in deal worth up to USD750m
Pharmaceutical giant GSK enters into an asset purchase agreement with Chimagen Biosciences valued at up to USD750 million
Firms guide Sunac’s USD9.6bn offshore debt restructuring
Sunac secured Hong Kong court approval for its USD9.6 billion offshore debt restructuring, backed by over 98% of creditors





















